Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|July 18, 2018
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN studyDaniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion TrialHolger N Lode, Nikolai Siebert, Dominique Valteau-Couanet, et al.
Pediatric Blood & Cancer|January 23, 2016
The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective StudyAndrea Ferrari, Salvatore Lo Vullo, Daniele Giardiello, et al.
Pediatric Blood & Cancer|November 21, 2022
Relapse after non-metastatic rhabdomyosarcoma: The impact of routine surveillance imaging on early detection and post-relapse survivalMichela Casanova, Luca Bergamaschi, Stefano Chiaravalli, et al.
Pediatric Blood & Cancer|May 1, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma groupKatia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2022
Relapsing pediatric non-rhabdomyosarcoma soft tissue sarcomas: The impact of routine imaging surveillance on early detection and post-relapse survivalCarlo Morosi, Luca Bergamaschi, Virginia Livellara, et al.
Cancer Research|September 3, 2009
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patientsLorena Passoni, Luca Longo, Paola Collini, et al.
Pediatric Blood & Cancer|April 3, 2020
How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?Michela Casanova, Elena Pagani Bagliacca, Matteo Silva, et al.
Frontiers in Oncology|February 9, 2026
Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisonsHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma RegistryRiccardo Haupt, Alberto Garaventa, Claudio Gambini, et al.
Pageof 15